Geron Corp (GERN) Stock Price News - Google Finance Get the latest Geron Corp (GERN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions
Geron Corporation - Investors Media Geron is a commercial-stage biopharmaceutical company with a first-in-class telomerase inhibitor that is approved in the United States for the treatment of certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia As the sole company with an oligonucleotide telomerase inhibitor approved by the FDA, we are exploring its potential across
Geron Corporation Common Stock (GERN) - Nasdaq Discover real-time Geron Corporation Common Stock (GERN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions
Geron (GERN) Stock Price, News Analysis - MarketBeat Geron Corporation (NASDAQ: GERN) is a clinical-stage biotechnology company dedicated to developing and commercializing novel treatments that target telomerase, an enzyme critical to cancer cell immortality